Medicine and Dentistry
Heart Failure
48%
Cohort Analysis
36%
Hazard Ratio
34%
Genetic Risk
30%
Hypokalemia
28%
Coronary Angiography
24%
All Cause Mortality
24%
Atrial Fibrillation
24%
Coronary Artery Disease
24%
Out of Hospital Cardiac Arrest
24%
Hip Fracture
24%
Iron Supplement
24%
COVID-19
24%
Population Dynamics
21%
Troponin
21%
Logistic Regression Analysis
18%
Cardiovascular Mortality
18%
Observational Study
17%
Anemia
16%
Proportional Hazards Model
16%
Single Nucleotide Polymorphism
15%
Diseases
15%
Cardiovascular Disease
14%
Genome Wide Association Study
12%
Cardiovascular System
12%
Drug Therapy
12%
Postoperative Infection
12%
Coronary Artery Bypass Surgery
12%
Apoplexy
12%
Biological Marker
12%
Onset Age
12%
Intensive Care Unit
12%
Genetic Variability
12%
Insulin Resistance
12%
Revascularization
12%
Psychoactive Drug
12%
Mental Hospital
12%
Ischemic Heart Disease
12%
Cardiology
12%
Acute Coronary Syndrome
12%
Iron Isomaltose
12%
Pleiotropy
12%
Blood Pressure
12%
Cardiac Troponin
12%
Coronary Vessel
12%
Cumulative Incidence
12%
Coronary Artery Bypass Graft
12%
Group Therapy
9%
Blood Transfusion
9%
Glomerular Filtration Rate
9%
Keyphrases
Short-term Mortality
40%
Serum Potassium
36%
Potassium
35%
Hypokalemia
31%
All-cause Mortality
27%
Short-term Prognosis
24%
Plasma Potassium
24%
Patients with Chronic Heart Failure
24%
Hazard Ratio
22%
Cardiovascular Mortality
21%
Hyperkalemia
19%
Potassium Levels
16%
Mortality Risk
15%
Combined Antihypertensive Therapy
13%
Atrial Fibrillation or Flutter
13%
Monotherapy
12%
Diuretics
12%
Registry Study
12%
Intravenous Iron Therapy
12%
Stroke Risk
12%
Population Control
12%
Nationwide Registry
12%
Atrial Fibrillation
12%
Patients with Hypertension
12%
Out-of-hospital Cardiac Arrest
12%
Survivors
12%
COVID-19 Severity
12%
Genetics of Resistance
12%
Electrocardiographic Characteristics
12%
Heart Failure
12%
Acute Coronary Syndrome
12%
Coronary Heart
12%
Myocardial Infarction
12%
Acute Heart Failure
12%
Multivariable
11%
Beta-blockers
9%
Confidence Interval
9%
Potassium Concentration
9%
IV Iron
9%
Procalcitonin
9%
Digoxin
7%
Increased Mortality
6%
Orthogeriatric Patients
6%
Intravenous Iron Supplement
6%
Coronary Vessel Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Isotopes of Potassium
100%
Heart Failure
48%
Hypokalemia
41%
Hyperkalemia
32%
All Cause Mortality
26%
Antihypertensive Therapy
25%
Disease
24%
Hip Fracture
24%
Cohort Study
24%
Renin-Angiotensin System Inhibitor
20%
Thiazide Diuretic Agent
18%
Anemia
16%
Cardiovascular Mortality
16%
Diuretic Agent
15%
Calcium Channel Blocker
15%
Beta Adrenergic Receptor Blocking Agent
15%
Observational Study
14%
Heart Infarction
14%
Intervention Trial
12%
Troponin
12%
Genetic Risk
12%
Heart Atrium Flutter
12%
Atrial Fibrillation
12%
Ischemic Heart Disease
12%
Postoperative Infection
12%
Procalcitonin
12%
Iron Isomaltose
12%
Coronavirinae
12%
Acute Heart Failure
12%
Monotherapy
10%
Combination Therapy
8%
Hypnotic
8%
Mortality Rate
6%
Non Insulin Dependent Diabetes Mellitus
6%
Hyperlipidemia
6%
Digoxin
6%
Heart Muscle Injury
5%